Global Point of Care Testing for Infectious Disease Market 2020 by Company, Regions, Type and Application, Forecast to 2025

$3480

Market Overview

The global Point of Care Testing for Infectious Disease market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Point of Care Testing for Infectious Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Point of Care Testing for Infectious Disease market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Point of Care Testing for Infectious Disease market has been segmented into:

Type I

Type II

By Application, Point of Care Testing for Infectious Disease has been segmented into:

Glucose

Lipids

HCV

HIV

Influenza

Urinalysis

Other

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Point of Care Testing for Infectious Disease market presented in the report. This section sheds light on the sales growth of different regional and country-level Point of Care Testing for Infectious Disease markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Point of Care Testing for Infectious Disease market.

The report offers in-depth assessment of the growth and other aspects of the Point of Care Testing for Infectious Disease market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Point of Care Testing for Infectious Disease Market Share Analysis

Point of Care Testing for Infectious Disease competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Point of Care Testing for Infectious Disease sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Point of Care Testing for Infectious Disease sales, revenue and market share for each player covered in this report.

The major players covered in Point of Care Testing for Infectious Disease are:

Abbott

PTS Diagnostics

Danaher

Roche

Instrumentation Laboratory

Siemens

Sekisui Diagnostics

Johnson & Johnson

Becton, Dickinson

Quidel (US), Chembio

Nova

Trinity Biotech

EKF Diagnostics

AccuBioTech

Table of Contents

1 Point of Care Testing for Infectious Disease Market Overview

1.1 Product Overview and Scope of Point of Care Testing for Infectious Disease

1.2 Classification of Point of Care Testing for Infectious Disease by Type

1.2.1 Global Point of Care Testing for Infectious Disease Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global Point of Care Testing for Infectious Disease Revenue Market Share by Type in 2019

1.2.3 Type I

1.2.4 Type II

1.3 Global Point of Care Testing for Infectious Disease Market by Application

1.3.1 Overview: Global Point of Care Testing for Infectious Disease Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Glucose

1.3.3 Lipids

1.3.4 HCV

1.3.5 HIV

1.3.6 Influenza

1.3.7 Urinalysis

1.3.8 Other

1.4 Global Point of Care Testing for Infectious Disease Market by Regions

1.4.1 Global Point of Care Testing for Infectious Disease Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of Point of Care Testing for Infectious Disease (2015-2025)

1.4.3 North America (USA, Canada and Mexico) Point of Care Testing for Infectious Disease Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) Point of Care Testing for Infectious Disease Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Point of Care Testing for Infectious Disease Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) Point of Care Testing for Infectious Disease Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Point of Care Testing for Infectious Disease Status and Prospect (2015-2025)

2 Company Profiles

2.1 Abbott

2.1.1 Abbott Details

2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Abbott SWOT Analysis

2.1.4 Abbott Product and Services

2.1.5 Abbott Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

2.2 PTS Diagnostics

2.2.1 PTS Diagnostics Details

2.2.2 PTS Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 PTS Diagnostics SWOT Analysis

2.2.4 PTS Diagnostics Product and Services

2.2.5 PTS Diagnostics Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

2.3 Danaher

2.3.1 Danaher Details

2.3.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Danaher SWOT Analysis

2.3.4 Danaher Product and Services

2.3.5 Danaher Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

2.4 Roche

2.4.1 Roche Details

2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Roche SWOT Analysis

2.4.4 Roche Product and Services

2.4.5 Roche Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

2.5 Instrumentation Laboratory

2.5.1 Instrumentation Laboratory Details

2.5.2 Instrumentation Laboratory Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Instrumentation Laboratory SWOT Analysis

2.5.4 Instrumentation Laboratory Product and Services

2.5.5 Instrumentation Laboratory Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

2.6 Siemens

2.6.1 Siemens Details

2.6.2 Siemens Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Siemens SWOT Analysis

2.6.4 Siemens Product and Services

2.6.5 Siemens Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

2.7 Sekisui Diagnostics

2.7.1 Sekisui Diagnostics Details

2.7.2 Sekisui Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Sekisui Diagnostics SWOT Analysis

2.7.4 Sekisui Diagnostics Product and Services

2.7.5 Sekisui Diagnostics Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

2.8 Johnson & Johnson

2.8.1 Johnson & Johnson Details

2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Johnson & Johnson SWOT Analysis

2.8.4 Johnson & Johnson Product and Services

2.8.5 Johnson & Johnson Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

2.9 Becton, Dickinson

2.9.1 Becton, Dickinson Details

2.9.2 Becton, Dickinson Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Becton, Dickinson SWOT Analysis

2.9.4 Becton, Dickinson Product and Services

2.9.5 Becton, Dickinson Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

2.10 Quidel (US), Chembio

2.10.1 Quidel (US), Chembio Details

2.10.2 Quidel (US), Chembio Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Quidel (US), Chembio SWOT Analysis

2.10.4 Quidel (US), Chembio Product and Services

2.10.5 Quidel (US), Chembio Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

2.11 Nova

2.11.1 Nova Details

2.11.2 Nova Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Nova SWOT Analysis

2.11.4 Nova Product and Services

2.11.5 Nova Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

2.12 Trinity Biotech

2.12.1 Trinity Biotech Details

2.12.2 Trinity Biotech Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 Trinity Biotech SWOT Analysis

2.12.4 Trinity Biotech Product and Services

2.12.5 Trinity Biotech Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

2.13 EKF Diagnostics

2.13.1 EKF Diagnostics Details

2.13.2 EKF Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 EKF Diagnostics SWOT Analysis

2.13.4 EKF Diagnostics Product and Services

2.13.5 EKF Diagnostics Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

2.14 AccuBioTech

2.14.1 AccuBioTech Details

2.14.2 AccuBioTech Major Business and Total Revenue (Financial Highlights) Analysis

2.14.3 AccuBioTech SWOT Analysis

2.14.4 AccuBioTech Product and Services

2.14.5 AccuBioTech Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Point of Care Testing for Infectious Disease Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 Point of Care Testing for Infectious Disease Players Market Share

3.2.2 Top 10 Point of Care Testing for Infectious Disease Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global Point of Care Testing for Infectious Disease Revenue and Market Share by Regions

4.2 North America Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

4.3 Europe Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

4.5 South America Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

5 North America Point of Care Testing for Infectious Disease Revenue by Countries

5.1 North America Point of Care Testing for Infectious Disease Revenue by Countries (2015-2020)

5.2 USA Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

5.3 Canada Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

5.4 Mexico Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

6 Europe Point of Care Testing for Infectious Disease Revenue by Countries

6.1 Europe Point of Care Testing for Infectious Disease Revenue by Countries (2015-2020)

6.2 Germany Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

6.3 UK Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

6.4 France Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

6.5 Russia Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

6.6 Italy Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Point of Care Testing for Infectious Disease Revenue by Countries

7.1 Asia-Pacific Point of Care Testing for Infectious Disease Revenue by Countries (2015-2020)

7.2 China Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

7.3 Japan Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

7.4 Korea Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

7.5 India Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

8 South America Point of Care Testing for Infectious Disease Revenue by Countries

8.1 South America Point of Care Testing for Infectious Disease Revenue by Countries (2015-2020)

8.2 Brazil Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

8.3 Argentina Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Point of Care Testing for Infectious Disease by Countries

9.1 Middle East & Africa Point of Care Testing for Infectious Disease Revenue by Countries (2015-2020)

9.2 Saudi Arabia Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

9.3 UAE Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

9.4 Egypt Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

9.5 South Africa Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global Point of Care Testing for Infectious Disease Revenue and Market Share by Type (2015-2020)

10.2 Global Point of Care Testing for Infectious Disease Market Forecast by Type (2019-2024)

10.3 Type I Revenue Growth Rate (2015-2025)

10.4 Type II Revenue Growth Rate (2015-2025)

11 Global Point of Care Testing for Infectious Disease Market Segment by Application

11.1 Global Point of Care Testing for Infectious Disease Revenue Market Share by Application (2015-2020)

11.2 Point of Care Testing for Infectious Disease Market Forecast by Application (2019-2024)

11.3 Glucose Revenue Growth (2015-2020)

11.4 Lipids Revenue Growth (2015-2020)

11.5 HCV Revenue Growth (2015-2020)

11.6 HIV Revenue Growth (2015-2020)

11.7 Influenza Revenue Growth (2015-2020)

11.8 Urinalysis Revenue Growth (2015-2020)

11.9 Other Revenue Growth (2015-2020)

12 Global Point of Care Testing for Infectious Disease Market Size Forecast (2021-2025)

12.1 Global Point of Care Testing for Infectious Disease Market Size Forecast (2021-2025)

12.2 Global Point of Care Testing for Infectious Disease Market Forecast by Regions (2021-2025)

12.3 North America Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)

12.4 Europe Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)

12.6 South America Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US


List of Tables

Table 1. Global Point of Care Testing for Infectious Disease Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Point of Care Testing for Infectious Disease by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Point of Care Testing for Infectious Disease Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market Point of Care Testing for Infectious Disease Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Abbott Corporate Information, Location and Competitors

Table 6. Abbott Point of Care Testing for Infectious Disease Major Business

Table 7. Abbott Point of Care Testing for Infectious Disease Total Revenue (USD Million) (2017-2018)

Table 8. Abbott SWOT Analysis

Table 9. Abbott Point of Care Testing for Infectious Disease Product and Solutions

Table 10. Abbott Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 11. PTS Diagnostics Corporate Information, Location and Competitors

Table 12. PTS Diagnostics Point of Care Testing for Infectious Disease Major Business

Table 13. PTS Diagnostics Point of Care Testing for Infectious Disease Total Revenue (USD Million) (2018-2019)

Table 14. PTS Diagnostics SWOT Analysis

Table 15. PTS Diagnostics Point of Care Testing for Infectious Disease Product and Solutions

Table 16. PTS Diagnostics Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 17. Danaher Corporate Information, Location and Competitors

Table 18. Danaher Point of Care Testing for Infectious Disease Major Business

Table 19. Danaher Point of Care Testing for Infectious Disease Total Revenue (USD Million) (2017-2018)

Table 20. Danaher SWOT Analysis

Table 21. Danaher Point of Care Testing for Infectious Disease Product and Solutions

Table 22. Danaher Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 23. Roche Corporate Information, Location and Competitors

Table 24. Roche Point of Care Testing for Infectious Disease Major Business

Table 25. Roche Point of Care Testing for Infectious Disease Total Revenue (USD Million) (2017-2018)

Table 26. Roche SWOT Analysis

Table 27. Roche Point of Care Testing for Infectious Disease Product and Solutions

Table 28. Roche Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 29. Instrumentation Laboratory Corporate Information, Location and Competitors

Table 30. Instrumentation Laboratory Point of Care Testing for Infectious Disease Major Business

Table 31. Instrumentation Laboratory Point of Care Testing for Infectious Disease Total Revenue (USD Million) (2017-2018)

Table 32. Instrumentation Laboratory SWOT Analysis

Table 33. Instrumentation Laboratory Point of Care Testing for Infectious Disease Product and Solutions

Table 34. Instrumentation Laboratory Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 35. Siemens Corporate Information, Location and Competitors

Table 36. Siemens Point of Care Testing for Infectious Disease Major Business

Table 37. Siemens Point of Care Testing for Infectious Disease Total Revenue (USD Million) (2017-2018)

Table 38. Siemens SWOT Analysis

Table 39. Siemens Point of Care Testing for Infectious Disease Product and Solutions

Table 40. Siemens Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 41. Sekisui Diagnostics Corporate Information, Location and Competitors

Table 42. Sekisui Diagnostics Point of Care Testing for Infectious Disease Major Business

Table 43. Sekisui Diagnostics Point of Care Testing for Infectious Disease Total Revenue (USD Million) (2017-2018)

Table 44. Sekisui Diagnostics SWOT Analysis

Table 45. Sekisui Diagnostics Point of Care Testing for Infectious Disease Product and Solutions

Table 46. Sekisui Diagnostics Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 47. Johnson & Johnson Corporate Information, Location and Competitors

Table 48. Johnson & Johnson Point of Care Testing for Infectious Disease Major Business

Table 49. Johnson & Johnson Point of Care Testing for Infectious Disease Total Revenue (USD Million) (2017-2018)

Table 50. Johnson & Johnson SWOT Analysis

Table 51. Johnson & Johnson Point of Care Testing for Infectious Disease Product and Solutions

Table 52. Johnson & Johnson Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 53. Becton, Dickinson Corporate Information, Location and Competitors

Table 54. Becton, Dickinson Point of Care Testing for Infectious Disease Major Business

Table 55. Becton, Dickinson Point of Care Testing for Infectious Disease Total Revenue (USD Million) (2017-2018)

Table 56. Becton, Dickinson SWOT Analysis

Table 57. Becton, Dickinson Point of Care Testing for Infectious Disease Product and Solutions

Table 58. Becton, Dickinson Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 59. Quidel (US), Chembio Corporate Information, Location and Competitors

Table 60. Quidel (US), Chembio Point of Care Testing for Infectious Disease Major Business

Table 61. Quidel (US), Chembio Point of Care Testing for Infectious Disease Total Revenue (USD Million) (2017-2018)

Table 62. Quidel (US), Chembio SWOT Analysis

Table 63. Quidel (US), Chembio Point of Care Testing for Infectious Disease Product and Solutions

Table 64. Quidel (US), Chembio Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 65. Nova Corporate Information, Location and Competitors

Table 66. Nova Point of Care Testing for Infectious Disease Major Business

Table 67. Nova Point of Care Testing for Infectious Disease Total Revenue (USD Million) (2017-2018)

Table 68. Nova SWOT Analysis

Table 69. Nova Point of Care Testing for Infectious Disease Product and Solutions

Table 70. Nova Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 71. Trinity Biotech Corporate Information, Location and Competitors

Table 72. Trinity Biotech Point of Care Testing for Infectious Disease Major Business

Table 73. Trinity Biotech Point of Care Testing for Infectious Disease Total Revenue (USD Million) (2017-2018)

Table 74. Trinity Biotech SWOT Analysis

Table 75. Trinity Biotech Point of Care Testing for Infectious Disease Product and Solutions

Table 76. Trinity Biotech Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 77. EKF Diagnostics Corporate Information, Location and Competitors

Table 78. EKF Diagnostics Point of Care Testing for Infectious Disease Major Business

Table 79. EKF Diagnostics Point of Care Testing for Infectious Disease Total Revenue (USD Million) (2017-2018)

Table 80. EKF Diagnostics SWOT Analysis

Table 81. EKF Diagnostics Point of Care Testing for Infectious Disease Product and Solutions

Table 82. EKF Diagnostics Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 83. AccuBioTech Corporate Information, Location and Competitors

Table 84. AccuBioTech Point of Care Testing for Infectious Disease Major Business

Table 85. AccuBioTech Point of Care Testing for Infectious Disease Total Revenue (USD Million) (2017-2018)

Table 86. AccuBioTech SWOT Analysis

Table 87. AccuBioTech Point of Care Testing for Infectious Disease Product and Solutions

Table 88. AccuBioTech Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 89. Global Point of Care Testing for Infectious Disease Revenue (Million USD) by Players (2015-2020)

Table 90. Global Point of Care Testing for Infectious Disease Revenue Share by Players (2015-2020)

Table 91. Global Point of Care Testing for Infectious Disease Revenue (Million USD) by Regions (2015-2020)

Table 92. Global Point of Care Testing for Infectious Disease Revenue Market Share by Regions (2015-2020)

Table 93. North America Point of Care Testing for Infectious Disease Revenue by Countries (2015-2020)

Table 94. North America Point of Care Testing for Infectious Disease Revenue Market Share by Countries (2015-2020)

Table 95. Europe Point of Care Testing for Infectious Disease Revenue (Million USD) by Countries (2015-2020)

Table 96. Asia-Pacific Point of Care Testing for Infectious Disease Revenue (Million USD) by Countries (2015-2020)

Table 97. South America Point of Care Testing for Infectious Disease Revenue by Countries (2015-2020)

Table 98. South America Point of Care Testing for Infectious Disease Revenue Market Share by Countries (2015-2020)

Table 99. Middle East and Africa Point of Care Testing for Infectious Disease Revenue (Million USD) by Countries (2015-2020)

Table 100. Middle East and Africa Point of Care Testing for Infectious Disease Revenue Market Share by Countries (2015-2020)

Table 101. Global Point of Care Testing for Infectious Disease Revenue (Million USD) by Type (2015-2020)

Table 102. Global Point of Care Testing for Infectious Disease Revenue Share by Type (2015-2020)

Table 103. Global Point of Care Testing for Infectious Disease Revenue Forecast by Type (2021-2025)

Table 104. Global Point of Care Testing for Infectious Disease Revenue by Application (2015-2020)

Table 105. Global Point of Care Testing for Infectious Disease Revenue Share by Application (2015-2020)

Table 106. Global Point of Care Testing for Infectious Disease Revenue Forecast by Application (2021-2025)

Table 107. Global Point of Care Testing for Infectious Disease Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Point of Care Testing for Infectious Disease Picture

Figure 2. Global Point of Care Testing for Infectious Disease Revenue Market Share by Type in 2019

Figure 3. Type I Picture

Figure 4. Type II Picture

Figure 5. Point of Care Testing for Infectious Disease Revenue Market Share by Application in 2019

Figure 6. Glucose Picture

Figure 7. Lipids Picture

Figure 8. HCV Picture

Figure 9. HIV Picture

Figure 10. Influenza Picture

Figure 11. Urinalysis Picture

Figure 12. Other Picture

Figure 13. Global Point of Care Testing for Infectious Disease Revenue (USD Million) and Growth Rate (2015-2025)

Figure 14. North America Point of Care Testing for Infectious Disease Revenue (Million USD) and Growth Rate (2015-2025)

Figure 15. Europe Point of Care Testing for Infectious Disease Revenue (Million USD) and Growth Rate (2015-2025)

Figure 16. Asia-Pacific Point of Care Testing for Infectious Disease Revenue (Million USD) and Growth Rate (2015-2025)

Figure 17. South America Point of Care Testing for Infectious Disease Revenue (Million USD) and Growth Rate (2015-2025)

Figure 18. Middle East and Africa Point of Care Testing for Infectious Disease Revenue (Million USD) and Growth Rate (2015-2025)

Figure 19. Global Point of Care Testing for Infectious Disease Revenue (Million USD) and Growth Rate (2015-2025)

Figure 20. Global Point of Care Testing for Infectious Disease Revenue Share by Players in 2019

Figure 21. Global Top 5 Players Point of Care Testing for Infectious Disease Revenue Market Share in 2019

Figure 22. Global Top 10 Players Point of Care Testing for Infectious Disease Revenue Market Share in 2019

Figure 23. Key Players Market Share Trend

Figure 24. Global Point of Care Testing for Infectious Disease Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 25. Global Point of Care Testing for Infectious Disease Revenue Market Share by Regions (2015-2020)

Figure 26. Global Point of Care Testing for Infectious Disease Revenue Market Share by Regions in 2018

Figure 27. North America Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 28. Europe Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 29. Asia-Pacific Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 30. South America Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 31. Middle East and Africa Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 32. North America Point of Care Testing for Infectious Disease Revenue Market Share by Countries (2015-2020)

Figure 33. North America Point of Care Testing for Infectious Disease Revenue Market Share by Countries in 2019

Figure 34. USA Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 35. Canada Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 36. Mexico Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 37. Europe Point of Care Testing for Infectious Disease Revenue Market Share by Countries (2015-2020)

Figure 38. Europe Point of Care Testing for Infectious Disease Revenue Market Share by Countries in 2019

Figure 39. Germany Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 40. UK Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 41. France Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 42. Russia Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 43. Italy Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 44. Asia-Pacific Point of Care Testing for Infectious Disease Revenue Market Share by Countries (2015-2020)

Figure 45. Asia-Pacific Point of Care Testing for Infectious Disease Revenue Market Share by Countries in 2019

Figure 46. China Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 47. Japan Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 48. Korea Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 49. India Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 50. Southeast Asia Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 51. South America Point of Care Testing for Infectious Disease Revenue Market Share by Countries (2015-2020)

Figure 52. South America Point of Care Testing for Infectious Disease Revenue Market Share by Countries in 2019

Figure 53. Brazil Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 54. Argentina Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 55. Middle East and Africa Point of Care Testing for Infectious Disease Revenue Market Share by Countries (2015-2020)

Figure 56. Middle East and Africa Point of Care Testing for Infectious Disease Revenue Market Share by Countries in 2019

Figure 57. Saudi Arabia Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 58. UAE Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 59. Egypt Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 60. South Africa Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

Figure 61. Global Point of Care Testing for Infectious Disease Revenue Share by Type (2015-2020)

Figure 62. Global Point of Care Testing for Infectious Disease Revenue Share by Type in 2019

Figure 63. Global Point of Care Testing for Infectious Disease Market Share Forecast by Type (2021-2025)

Figure 64. Global Type I Revenue Growth Rate (2015-2020)

Figure 65. Global Type II Revenue Growth Rate (2015-2020)

Figure 66. Global Point of Care Testing for Infectious Disease Revenue Share by Application (2015-2020)

Figure 67. Global Point of Care Testing for Infectious Disease Revenue Share by Application in 2019

Figure 68. Global Point of Care Testing for Infectious Disease Market Share Forecast by Application (2021-2025)

Figure 69. Global Glucose Revenue Growth Rate (2015-2020)

Figure 70. Global Lipids Revenue Growth Rate (2015-2020)

Figure 71. Global HCV Revenue Growth Rate (2015-2020)

Figure 72. Global HIV Revenue Growth Rate (2015-2020)

Figure 73. Global Influenza Revenue Growth Rate (2015-2020)

Figure 74. Global Urinalysis Revenue Growth Rate (2015-2020)

Figure 75. Global Other Revenue Growth Rate (2015-2020)

Figure 76. Global Point of Care Testing for Infectious Disease Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 77. Global Point of Care Testing for Infectious Disease Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 78. Global Point of Care Testing for Infectious Disease Revenue Market Share Forecast by Regions (2021-2025)

Figure 79. North America Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)

Figure 80. Europe Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)

Figure 81. Asia-Pacific Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)

Figure 82. South America Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)

Figure 83. Middle East and Africa Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)

Figure 84. Sales Channel: Direct Channel vs Indirect Channel

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

  • Market research helps businesses strengthen a company’s position
  • Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
  • Market research helps in identifying the potential threats and opportunities associated with the business industry
  • Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

  • Data Collection
  • Data Synthesis
  • Market Deduction & Formulation
  • Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

  • Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
  • Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends. 
  • Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information. 
    • We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:
      • Export & Import Data
      • Business Information related to trade and its statistics
      • Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.
  • In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
  • Examining demographic along with psychographic segmentation for market evaluation
  • Analyzing the macro and micro-economic indicators for each demography
  • Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

  • Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
  • Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology. 
    • Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.
    • The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample


+1

Our Clients

Some Facts about Fior Markets

1%

Free Customization

1+

Countries can be added on demand

1

Free yearly update on purchase of Multi/Corporate User License

1+

Companies served till date

Customized Research Programme
Premium Customer Service

We serve our customers 24x7 for 365 days through calls, emails and live chat options.

Syndicated market research
Exceptional Market Report

Huge database of exceptional market reports bringing market intelligence to your fingertips.

Domain Specific Analytics
Secured Payment Options

SSL enabled, we offer you various secured payment options for risk free purchase.